Filing Flows › Cronos Group (CRON) › Q2 2026 › vs Q2 2025
Cronos Group (CRON) Q2 2026 vs Q2 2025 (year over year)
Cronos Group's revenue rose $26.3M (+60%) from $44.3M in Q2 2025 to $70.6M in Q2 2026. The biggest changes: Cannabis flower +$14.2M (+57%); Other revenues +$6.8M (+63%); Cannabis extracts +$5.4M (+65%). Gross margin 40.3% against 32.8% (+7.5 pts).
Cronos Group, Q2 2026: revenue $70.6M (+60% year over year), operating margin 10.5%, net earnings $32.1M, operating cash flow $24.0M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 40.3% | 32.8% | +7.5 pts |
| Operating margin | 10.5% | -12.0% | +22.5 pts |
| Net margin | 45.4% | -89.7% | +135.2 pts |
| Free cash flow margin | 31.5% | -2.3% | +33.8 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Cannabis flower | $39.2M | $25.0M | $14.2M | +57% |
| Cannabis extracts | $13.8M | $8.4M | $5.4M | +65% |
| Other | $19K | $70K | −$51K | -73% |
| Other revenues | $17.6M | $10.8M | $6.8M | +63% |
| Revenue | $70.6M | $44.3M | $26.3M | +60% |
| Gross profit | $28.5M | $14.5M | $13.9M | +96% |
| Cost of revenue | $42.1M | $29.7M | $12.4M | +42% |
| Other income, net | $28.3M | −$33.7M | $62.0M | — |
| Operating profit | $7.4M | −$5.3M | $12.7M | — |
| Operating expenses | $21.0M | $19.8M | $1.2M | +6% |
| Pre-tax earnings | $35.7M | −$39.0M | $74.7M | — |
| Research & development | $1.2M | $929K | $286K | +31% |
| Sales & marketing | $6.8M | $5.3M | $1.4M | +27% |
| General & admin | $10.8M | $10.5M | $267K | +3% |
| Other operating costs | $2.2M | $3.0M | −$772K | -26% |
| Net earnings | $32.1M | −$39.7M | $71.8M | — |
| Minority interests | $3.6M | $1.2M | $2.3M | +191% |
| Income tax | $51K | −$525K | $576K | — |
| Depreciation & amortization | $3.4M | $4.2M | −$828K | -20% |
| Share-based compensation | $1.6M | $1.4M | $176K | +13% |
| Working capital & other | $13.0M | −$36.9M | $50.0M | — |
| Operating cash flow | $24.0M | $2.8M | $21.2M | +752% |
| Free cash flow (OCF − capex) | $22.3M | −$1.0M | $23.3M | — |
| Capital expenditures | $1.7M | $3.8M | −$2.1M | -55% |
Questions
How much did Cronos Group's revenue grow year over year in Q2 2026?
Cronos Group's revenue rose $26.3M (+60%) from $44.3M in Q2 2025 to $70.6M in Q2 2026.
What drove Cronos Group's revenue change in Q2 2026?
Cannabis flower +$14.2M (+57%); Other revenues +$6.8M (+63%); Cannabis extracts +$5.4M (+65%).